PharmaCielo Ltd. (TSXV:PCLO) (OTCQX: PCLOF), released financial results for the third quarter ended September 30, 2022, revealing total revenue of CA$475,323 ($348,000), a 2% decrease compared to CA$485,165 in Q3 2021.

Q3 Financial Highlights

Bill Petron, chairman and CEO of PharmaCielo stated, "Our team has successfully implemented the turnaround plan we outlined for shareholders when I joined as CEO in August of last year. In the first nine months of 2022, our business development group has initiated shipments to …

Full story available on